In the Know – October 2018
VOLUME 13, ISSUE 10 RESEARCH NEWS RG6042 (FORMERLY KNOWN AS IONIS-HTTRX) HUNTINGTIN-LOWERING TRIAL INFORMATION ROCHE HUNTINGTIN-LOWERING UPDATE –
Read more
VOLUME 13, ISSUE 10 RESEARCH NEWS RG6042 (FORMERLY KNOWN AS IONIS-HTTRX) HUNTINGTIN-LOWERING TRIAL INFORMATION ROCHE HUNTINGTIN-LOWERING UPDATE –
Read more
Caring for Carers & Families with HD Living with Huntington disease (HD) is challenging for people who are affected by
Read more
Volume 13, Issue 8 RESEARCH NEWS Roche RG6042 Update PRIME Designation Granted by European Medicines Agency for RG6042 for Treatment
Read more
Read the HDBuzz summary here! Active Biotech releases new updates on Legato-HD trial in recent press release: (Lund Sweden) July
Read more
Tips When Working With Individuals Affected by HD The nature of Huntington disease (HD) means that a person living with
Read more
Volume 13, Issue 7 HSC Welcomes New CEO Getting to Know Robin Markowitz, HSC’s New CEO Today, July 16,
Read more
The Huntington Society of Canada (HSC) supports an amazing program that brings youth from all over the country together. Young People
Read more
The Huntington Society of Canada (HSC) supports an amazing program that brings youth from all over the country together. Young People
Read more
Volume 13, Issue 6 ANNOUNCING HSC’S NEW CEO Huntington Society of Canada’s Board of Directors Appoints New CEO The
Read more
The Huntington Society of Canada (HSC) currently has an opportunity for a social worker to take on the role of
Read more